Biohaven Pharmaceutical Holding Company Ltd. BHVN
$ 44.12
-1.45%
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2022-Q2
добавлен 16.12.2023
Biohaven Pharmaceutical Holding Company Ltd. Мультипликаторы 2011-2024 | BHVN
Мультипликаторы по годам Biohaven Pharmaceutical Holding Company Ltd.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-10.2 | -6.5 | -4.4 | -6.5 | -7.6 | - | - | - | - | - | - |
P/S |
18.6 | 78.7 | - | - | - | - | - | - | - | - | - |
EPS |
-13.1 | -13.1 | -10.9 | -6.2 | -5 | -5.0 | -0.9 | - | - | - | - |
EV (Enterprise Value) |
10.2 млрд | 5.89 млрд | 2.39 млрд | 1.43 млрд | 846 млн | -13.7 млн | -655 тыс. | - | - | - | - |
EBITDA per Share |
-10.5 | -10.8 | -9.87 | -1.17 | -3.86 | - | - | - | - | - | - |
EV/EBITDA |
-14.9 | -0.2 | -4.2 | -6.0 | -6.4 | - | - | - | - | - | - |
PEG |
- | 0.0 | 0.06 | 0.27 | 0.62 | - | - | - | - | - | - |
P/B |
-12.6 | -15.1 | -316.7 | 10.3 | 7.3 | - | - | - | - | - | - |
P/CF |
-10.3 | -7.1 | -6.2 | -7.9 | -10.1 | - | - | - | - | - | - |
ROE % |
114.50 | 196.43 | 7122.91 | -159.64 | -96.38 | - | - | - | - | - | - |
ROA % |
-78.59 | -111.62 | -153.60 | -83.07 | -86.59 | - | - | - | - | - | - |
ROCE % |
95.22 | -156.63 | -172.29 | -17.77 | -78.26 | - | - | - | - | - | - |
Current Ratio |
0.6 | 0.7 | 1.0 | 2.1 | 9.8 | - | - | - | - | - | - |
DSO |
169.0 | 344.5 | - | - | - | - | - | - | - | - | - |
DIO |
239.3 | 408.1 | - | - | - | - | - | - | - | - | - |
DPO |
199.4 | 645.1 | - | - | - | - | - | - | - | - | - |
Операционный цикл |
408.3 | 752.6 | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
208.9 | 107.5 | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Biohaven Pharmaceutical Holding Company Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | - | -6.21 | -2.97 | - | -2.63 | -3.23 | -4.27 | -3.62 | -3.27 | -3.08 | -3.07 | -2.85 | -2.04 | -4.67 | -1.41 | -1.34 | -1.53 | -1.01 | -2.32 | -0.75 | -1.19 | -1.78 | -1.74 | -1.96 | -2.16 | -0.55 | -0.25 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -4.08 | -0.7 | - | -2.14 | -2.64 | -3.72 | -2.84 | -2.66 | -2.67 | -2.67 | -2.58 | -1.73 | -4.4 | -1.23 | -1.17 | -1.37 | -0.98 | -2.27 | -0.79 | -1.1 | -0.97 | -1.11 | -1.75 | -2.14 | -0.55 | -0.25 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
135.41 | 109.46 | 138.68 | 129.75 | 170.86 | 226.63 | 288.70 | 752.61 | 701.53 | 2656.31 | 3995.07 | 6327.99 | 7122.91 | 5076.07 | 3605.31 | 736.22 | -159.64 | -143.88 | -130.64 | -124.56 | -25.43 | 51.64 | 141.87 | 176.95 | 141.01 | 84.45 | 21.70 | 6.55 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-72.27 | -55.59 | -70.78 | -63.86 | -66.60 | -98.30 | -108.07 | -125.75 | -131.77 | -143.43 | -149.31 | -167.97 | -153.60 | -129.13 | -119.47 | -71.70 | -83.07 | -82.63 | -90.66 | -103.29 | -89.31 | -165.15 | -240.53 | -239.60 | -235.03 | -140.76 | -36.16 | -10.92 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
83.86 | 71.50 | 95.30 | 96.79 | 146.18 | 189.90 | 242.41 | 657.55 | 611.49 | 2386.04 | 3528.16 | 5758.72 | 6453.69 | 4603.56 | 3348.74 | 640.13 | -148.79 | -138.39 | -127.32 | -115.14 | -32.78 | 39.39 | 126.83 | 155.10 | 134.65 | 83.93 | 21.83 | 6.62 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | - | 0.6 | 0.8 | 0.6 | 0.7 | 0.7 | 0.8 | 0.7 | 0.8 | 0.9 | 1.3 | 1.0 | 1.0 | 1.0 | 1.0 | 2.1 | 2.1 | 2.1 | 2.1 | 9.8 | 9.8 | 9.8 | 9.8 | 0.9 | 0.9 | 0.9 | 0.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | 91.1 | - | 141.7 | 159.8 | 288.3 | 312.1 | 620.5 | 1130.1 | 4761.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | 297.7 | - | 248.4 | 322.0 | 347.2 | 273.2 | 312.9 | 202.2 | 493.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | 186.9 | - | 195.7 | 327.8 | 401.0 | 423.2 | 656.0 | 697.5 | 4710.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | 388.8 | - | 390.1 | 481.8 | 635.5 | 674.3 | 933.3 | 1332.3 | 5254.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | 201.9 | - | 194.4 | 154.0 | 234.5 | 230.5 | 277.3 | 634.9 | 543.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD